Comorbidity of substance use and depressive symptomology: A retrospective analysis of their relation and trajectory across adolescence

2011 ◽  
Author(s):  
Amy Trevethan
Keyword(s):  
Substance Use ◽  
Retrospective Analysis ◽  
Depressive Symptomology

Retrospective Analysis of Oxcarbazepine in Pregnant Women With Substance Use Disorders: Focus on Safety

2019 ◽  
pp. 089719001985070
Author(s):  
Kayla D. Johnson ◽  
Lindsey N. Miller ◽  
Jonathon D. Pouliot ◽  
Peter R. Martin
Keyword(s):  
Substance Use ◽  
Pregnant Women ◽  
Retrospective Analysis ◽  
Substance Use Disorders

Profiles of Substance Use in Adolescents With Severe Obesity

2020 ◽  
pp. 0044118X2096838
Author(s):  
Jennifer N. Becnel ◽  
Zachary Giano ◽  
Amanda L. Williams ◽  
Michael J. Merten
Keyword(s):  
Substance Use ◽  
Latent Profile Analysis ◽  
Severe Obesity ◽  
Longitudinal Research ◽  
Profile Analysis ◽  
Poor Mental Health ◽  
Depressive Symptomology ◽  
Obese Youth ◽  
Severely Obese ◽  
Using Data

A growing body of literature suggests that youth with severe obesity are engaging in substance use. The purpose of the present study was to examine profiles of substance use among adolescents with severe obesity and examine how these profiles are associated with depressive symptomology using data from the Youth Risk Behavior Surveillance System. The sample included 597 girls and 626 boys who self-reported height and weight and alcohol, tobacco, marijuana, and illicit substance use. Latent profile analysis revealed four distinct groups ranging from non-users to polysubstance users with non-users reporting the highest depressive symptoms. These results suggest those with severe obesity might be using substances to self-medicate to treat poor mental health; however, longitudinal research is necessary to examine pathways to substance use among severely obese youth.

Sound Production Treatment for Acquired Apraxia of Speech: An Examination of Dosage in Relation to Probe Performance

2020 ◽  
pp. 1-16
Author(s):  
Julie L. Wambaugh ◽  
Lydia Kallhoff ◽  
Christina Nessler
Keyword(s):  
Retrospective Analysis ◽  
Sound Production ◽  
Apraxia Of Speech ◽  
Practice Schedule ◽  
Practice Schedules ◽  
Baseline Performance ◽  
The Mean ◽  
Number Of Treatment ◽  
The Impact

Purpose This study was designed to examine the association of dosage and effects of Sound Production Treatment (SPT) for acquired apraxia of speech. Method Treatment logs and probe data from 20 speakers with apraxia of speech and aphasia were submitted to a retrospective analysis. The number of treatment sessions and teaching episodes was examined relative to (a) change in articulation accuracy above baseline performance, (b) mastery of production, and (c) maintenance. The impact of practice schedule (SPT-Blocked vs. SPT-Random) was also examined. Results The average number of treatment sessions conducted prior to change was 5.4 for SPT-Blocked and 3.9 for SPT-Random. The mean number of teaching episodes preceding change was 334 for SPT-Blocked and 179 for SPT-Random. Mastery occurred within an average of 13.7 sessions (1,252 teaching episodes) and 12.4 sessions (1,082 teaching episodes) for SPT-Blocked and SPT-Random, respectively. Comparisons of dosage metric values across practice schedules did not reveal substantial differences. Significant negative correlations were found between follow-up probe performance and the dosage metrics. Conclusions Only a few treatment sessions were needed to achieve initial positive changes in articulation, with mastery occurring within 12–14 sessions for the majority of participants. Earlier occurrence of change or mastery was associated with better follow-up performance. Supplemental Material https://doi.org/10.23641/asha.12592190

Sign in / Sign up

Export Citation Format

Share Document